Loading…
Arkema announced Bostik's investment of about US$11 million in CMC, a joint venture with Cartell Chemical Co, to produce specialty cyanoacrylate monomers on an industrial scale for engineering adhesives.
Arkema's subsidiary Bostik has invested approximately $11 million in a joint venture with Taiwanese company Cartell Chemical Co, named CMC (Crackless Monomer Company). Bostik will own 51% of the JV, which will produce specialty cyanoacrylate monomers for high value-added engineering adhesives.
Arkema's Bostik is investing around $11 million in CMC, a joint venture with Cartell Chemical Co, to produce specialty cyanoacrylate monomers on an industrial scale for engineering adhesives used in electronics, medical equipment, and DIY markets.